Results 21 to 30 of about 248,430 (244)
Health Technology Assessment in Action, 2017 Context: Application of anti-clot drugs such as recombinant tissue plasminogen activator (rt-PA) to treat patients with strokes is considered as a standard treatment employed through two techniques: intra-arterial and intravenous thrombolysis.
Mojtaba Nouhi +4 more
doaj +1 more source
Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke [Corrigendum]
Neuropsychiatric Disease and Treatment, 2022 Li N, Li J, Gao T, Wang D, Du Y, Zhao X. Neuropsychiatr Dis Treat. 2021;17:305–314. The authors have advised that the r value of intravenous thrombolysis in correlation with the Tandem scale in Table 4 and Table S2 is incorrect.
Li N, Li J, Gao T, Wang D, Du Y, Zhao X
doaj
Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke [PDF]
Stroke, 2011 Background and Purpose— Demographic changes will result in a rapid increase of patients age ≥90 years (nonagenarians), but little is known about outcomes in these patients after intravenous thrombolysis (IVT) for acute ischemic stroke.
Sarikaya, Hakan +13 more
openaire +5 more sources
Frontiers in Neurology, 2014 Background and Purpose: Cardiac myxoma is a rare etiology of stroke. Both cerebral microbleeds and cardiac myxoma may increase the risk of intracerebral hemorrhage after intravenous thrombolysis. However, data is still limited.
Aurauma eChutinet +6 more
doaj +1 more source
Time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke
Journal of the Formosan Medical Association, 2015 Background/Purpose: Intravenous thrombolysis for ischemic stroke saves societal costs. The aim of this study was to investigate the cost burden that hospitals may shoulder.
Mu-Chien Sun, Pi-Ju Hsiao
doaj +1 more source
Development of a computerised decision aid for thrombolysis in acute stroke care [PDF]
, 2015 Background - Thrombolytic treatment for acute ischaemic stroke improves prognosis, although there is a risk of bleeding complications leading to early death/severe disability. Benefit from thrombolysis is time dependent and treatment must be administered
Ford, Gary +9 more
core +1 more source
Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) [PDF]
, 2008 <p><b>Background and Purpose:</b> The Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) unadjusted results demonstrated that intravenous alteplase is well tolerated and that the effects were comparable with ...
Wahlgren, N. +92 more
core +1 more source
Паёми Сино, 2023 Objective: The gold standard treatment for patients with cerebral infarction (CI) is intravenous thrombolysis, and it is superior to standard therapy in improving functional status.
S.M. SEHWEIL
doaj +1 more source
Frontiers in Neurology, 2022 BackgroundHemorrhagic transformation (HT) is the most serious complication of ischemic stroke patients after intravenous thrombolysis and leads to a poor clinical prognosis.
Miaomiao Yang +4 more
doaj +1 more source
Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases [PDF]
, 2013 We present the case of an aphasic 77-year-old stroke patient with left distal M1 occlusion who received rt-PA for thrombolysis while on oral anticoagulant treatment with dabigatran (150 mg b.i.d.).
Baas, Horst +7 more
core +1 more source